Manmeet Singh Soni Summit Therapeutics Inc. (SMMT) insider trading activity

Manmeet Singh Soni is COO and CFO of Summit Therapeutics Inc.. Currently has a direct ownership of 3.07 Million shares of SMMT, which is worth approximately $56.1 Million. The most recent transaction as insider was on Oct 21, 2025, when has been sold 53,361 shares (Common Stock) at a price of $18.74 per share, resulting in proceeds of $999,985. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 3.07M

1.77% 3M change

1.77% 12M change

Total Value Held $56.1 Million

Manmeet Singh Soni Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Oct 21 2025	BUY Grant, award, or other acquisition	$999,985 $18.74 p/Share	53,361 Added 1.71%	3,073,603 Common Stock
Sep 11 2024	BUY Grant, award, or other acquisition	$999,980 $22.7 p/Share	44,052 Added 1.44%	3,020,242 Common Stock
Oct 13 2023	BUY Open market or private purchase	$4,999,999 $1.68 p/Share	2,976,190 Added 50.0%	2,976,190 Common Stock

Also insider at

RETA

REATA PHARMACEUTICALS INC Healthcare

COO, CFO and President

PLSE

Pulse Biosciences, Inc. Healthcare

Director

MSS